-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk announced on May 16 that CEO Zhou Fude will step down. He will continue as CEO for a while to support the company's smooth transition to new leadership. The statement said that considering recent market challenges, the decline in the company's stock price, and the expectations of the Novo Nordisk Foundation, Novo Nordisk's board of directors and Zhou Fude agreed that initiating the CEO succession process is in the best interests of the company and shareholders.

Zhitongcaijing·05/16/2025 11:09:03
Listen to the news
Novo Nordisk announced on May 16 that CEO Zhou Fude will step down. He will continue as CEO for a while to support the company's smooth transition to new leadership. The statement said that considering recent market challenges, the decline in the company's stock price, and the expectations of the Novo Nordisk Foundation, Novo Nordisk's board of directors and Zhou Fude agreed that initiating the CEO succession process is in the best interests of the company and shareholders.